| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscapeCom...
Pfizer plans to sell its remaining BioNTech stake through a $508 million block trade, ending a profitable Covid-19 vaccine part...
Metsera (NASDAQ:MTSR) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.69) by ...
Novo Nordisk shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc.